Zhu Hongli, Du Qianqian, Chen Chao, Chang Thomas Ming Swi
National Engineering Research Center for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, Shaanxi, China.
Artif Cells Blood Substit Immobil Biotechnol. 2010 Apr;38(2):57-63. doi: 10.3109/10731191003634232.
Crosslinking of ultrapure hemoglobin, crystalline catalase, and superoxide dismutase resulted in a soluble nanodimensional complex of polyhemoglobin-catalase-superoxide dismutase. A less expensive and more convenient way is to crosslink bovine stroma-free hemolysate (stroma-free hemolysate) that already contains hemoglobin, catalase, and superoxide dismutase into polyhemoglobin with catalase and superoxide dismutase activities (stroma-free polyhemolysate) [21]. The objective of the present study is to evaluate the immunological properties of this stroma-free polyhemolysate. Each of three groups of rats received weekly subcutaneous injections of one of the stroma-free polyhemolysate, stroma-free hemolysate, and saline for four weeks. One week after the four cycles of weekly immunization, serum and plasma were collected for C3a complement activation tests and Ouchterlony antibody-antigen precipitation tests, respectively. Results show that stroma-free polyhemolysate retained significant antioxidant enzyme activity. The C3a complement activation test and Ouchterlony test show that four weekly subcutaneous injections of bovine stroma-free polyhemolysate did not result in any immunological reaction in rats when tested this way.
超纯血红蛋白、结晶过氧化氢酶和超氧化物歧化酶交联后形成了一种可溶性的聚血红蛋白-过氧化氢酶-超氧化物歧化酶纳米复合物。一种成本更低且更便捷的方法是将已含有血红蛋白、过氧化氢酶和超氧化物歧化酶的牛去基质溶血产物(去基质溶血产物)交联成具有过氧化氢酶和超氧化物歧化酶活性的聚血红蛋白(去基质聚溶血产物)[21]。本研究的目的是评估这种去基质聚溶血产物的免疫学特性。三组大鼠每组每周皮下注射一次去基质聚溶血产物、去基质溶血产物和生理盐水,共注射四周。在每周免疫四个周期后的一周,分别采集血清和血浆用于C3a补体激活试验和双向免疫扩散抗体-抗原沉淀试验。结果表明,去基质聚溶血产物保留了显著的抗氧化酶活性。C3a补体激活试验和双向免疫扩散试验表明,以这种方式测试时,每周皮下注射四次牛去基质聚溶血产物不会在大鼠中引发任何免疫反应。